The litigation, filed as Operating Engineers Construction Industry and Miscellaneous Pension Fund v. PROCEPT BioRobotics Corporation, claims executives failed to disclose critical information during the specified period. Plaintiffs assert that U.S. handpiece sales consistently lagged behind reported figures, leading to an accumulation of over 10,000 excess units in the field. This inventory imbalance allegedly forced the company to miss annual revenue targets, rendering previous financial statements misleading. ClaimsFiler, an investor service, is currently directing affected shareholders to legal counsel at Kahn Swick & Foti, LLC to evaluate potential recovery options.
Investors Face September Deadline in PROCEPT BioRobotics Securities Suit
Investors who lost more than $100,000 in PROCEPT BioRobotics shares between February 2024 and February 2026 have until September 22 to file as lead plaintiffs. The class action lawsuit, currently pending in the Northern District of California, alleges the company misled shareholders regarding its handpiece sales and inventory levels.
Comments (0)
No comments yet. Be the first!